DERM / Journey Medical (DERM) to Post Skin Disease Data, Stock Rises 26%

Company to host conference call to discuss financial results and provide a corporate update on November 7, 2023 at 4:30 p.m. ET Company to host confer more_horizontal

Journey Medical Corporation (NASDAQ:DERM ) Q2 2023 Earnings Conference Call August 8, 2023 4:00 PM ET Company Participants Matt Blazei - CoreIR Claude more_horizontal

Journey Medical Corporation (DERM) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.34. This comp more_horizontal

Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023 Company to host conference call more_horizontal

Journey Medical (DERM) rises 26% on Monday after announcing the tentative date for reporting top-line results from its late-stage studies evaluating D more_horizontal

Journey Medical's (DERM) phase I study, assessing the impact of DFD-29 on the microbial flora of healthy adults, obtains its primary endpoints. more_horizontal

Journey Medical Corporation (DERM) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.44. This comp more_horizontal

Journey Medical Corp (NASDAQ:DERM ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Matt Blazei - CORE IR Claude Marao more_horizontal